News

Filter

1 to 9 of 19 results

ASH 2013: Meeting highlights from Novartis, Takeda, Biogen Idec and SOBI

ASH 2013: Meeting highlights from Novartis, Takeda, Biogen Idec and SOBI

10-12-2013

This year’s American Society of Hematology (ASH) meeting continued yesterday with more clinical trial…

Biogen IdecEloctateHematologyJakaviNovartisPharmaceuticalResearchSobiTakeda PharmaceuticalsUSA

ASH 2013: Meeting highlights from Takeda, Roche, Novartis and Gilead

ASH 2013: Meeting highlights from Takeda, Roche, Novartis and Gilead

09-12-2013

The 55th American Society of Hematology (ASH) meeting began in New Orleans on Saturday with a host of…

Gilead SciencesNorth AmericaNovartisPharmaceuticalResearchRocheTakeda Pharmaceuticals

Playing ball with Russia in the pharma sector

16-09-2012

Commenting on last week's announcement that Takeda Pharmaceuticals (TYO: 4502) had completed its $96…

EuropeNovartisPharmaceuticalPoliticsProductionTakeda PharmaceuticalsTeva Pharmaceutical Industries

1 to 9 of 19 results

Back to top